Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast Cancer

NCT02598310 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Estrogen Receptor Negative Neoplasm
HER-2 Positive Breast Cancer

Interventions

DRUG: nab-paclitaxel
DRUG: Trastuzumab

Sponsor

Osaka Medical College